Abstract Hypoxia-inducible factors (HIFs) locate to HIF-binding sites (HBSs) within the hypoxia-response elements (HREs) of oxygen-regulated genes. Whereas HIF-1α is expressed ubiquitously, HIF-2α is found primarily in the endothelium, similar to endothelin-1 (ET-1) and fms-like tyrosine kinase 1 (Flt-1), the expression of which is controlled by HREs. We identified an unique sequence alteration in both ET-1 and Flt-1 HBSs not found in other HIF-1 target genes, implying that these HBSs might cause binding of HIF-2 rather than HIF-1. However, electrophoretic mobility shift assays showed HIF-1 and HIF-2 DNA complex formation with the unique ET-1 HBS to be about equal. Both DNA-binding and hypoxic activation of reporter genes using the ET-1 HBS was decreased compared with transferrin and erythropoietin HBSs. The Flt-1 HBS was non-functional when assayed in isolation, suggesting that additional factors are required for hypoxic up-regulation via the reported Flt-1 HRE. Interestingly, HIF-1 activity could be restored fully by point-mutating the ET-1 (but not the Flt-1) HBS, suggesting that the wild-type ET-1 HBS attenuated the full hypoxic response known from other oxygen-regulated genes. Such a mechanism might serve to limit the expression of this potent vasoconstrictor in hypoxia.
Introduction
Limited O 2 supply (hypoxia) can alter the expression pattern of a specific set of genes involved in mammalian O 2 homeostasis, such as those encoding erythropoietin (EPO), transferrin or vascular endothelial growth factor (VEGF). Analysis of the 3′-flanking region of the EPO gene revealed the presence of an hypoxia-response element (HRE) binding the transcription factor hypoxiainducible factor-1 (HIF-1, reviewed in [57, 72] ). HIF-1 is a ubiquitously expressed α 1 β 1 heterodimer that specifically recognizes the HIF-binding site (HBS) within a HRE [70] . Under normoxic conditions, the von-HippelLindau tumour suppressor protein (pVHL) targets the HIF α-subunits for rapid ubiquitination and proteasomal degradation [44] . pVHL binding requires prolylhydroxylation of the HIF α-subunits, a protein modification that is directly dependent on O 2 [28, 30] . HIF-1β, previously identified [24] as the aryl hydrocarbon receptor nuclear translocator (ARNT), is required to form a functional DNA-binding complex, but not for hypoxic HIF-1α induction and nuclear translocation [6, 31] . Knock-out mouse models have demonstrated the major role of HIF-1 in O 2 homeostasis affecting the expression of a whole variety of O 2 -regulated genes [5, 29, 56] .
Recently, HIF-2α [10, 16, 25, 65] and HIF-3α [22] have been identified and show a more restricted expression pattern. HIF-2α is expressed mainly in endothelial cells [65] and in the organ of Zuckerkandl, the major site of fetal catecholamine production [66] . Other reports have also shown HIF-2α mRNA expression in smooth muscle cells of the uterus, neurons and brown adipose tissue [16] and in stromal cells of haemangioblastomas [17] . HIF-2α plays a major role in the regulation of fetal catecholamine production and in vascular remodelling during developmental vasculogenesis [53, 66] . In con-trast to the in vivo expression pattern, HIF-2α expression is widespread in in vitro cultured cells [75] and functional comparison between HIF-1α and HIF-2α has revealed many similarities [11, 26, 44, 51, 75] . Expression of all three HIF α-subunits has also been observed in the liver [33] although the detailed expression pattern and functional role of HIF-3α still remain to be elucidated.
The majority of the reported HIF-1-regulated genes are involved in O 2 homeostasis at the cellular, local and systemic levels. At the local level, for example, HIF-1 activates VEGF, which in turn induces angiogenesis, thus leading to an increase in vascular density and, hence, O 2 supply. VEGF (VEGF-A) and its two receptors (VEGFR) fms-like tyrosine kinase (Flt-1, VEGFR-1) and fetal liver kinase-1/kinase insert domain-containing receptor (Flk-1/ KDR, VEGFR-2) are important regulators of physiological and pathological (e.g. in solid tumour formation) blood vessel growth [13] . Endothelin-1 (ET-1) modulates local blood circulation by regulating vascular tone and blood pressure. ET-1, a 21-amino acid peptide synthesized and secreted by vascular endothelial cells, is among the most potent endogenous vasoconstrictors known [47] . Hypoxia is an important inducer of ET-1 [34] and might also be responsible for increased ET-1 production during myocardial ischaemia [71] .
It has been suggested that both Flt-1 [19] and ET-1 [27] are up-regulated transcriptionally by HIF-1 under hypoxic conditions. Interestingly, sequence comparison of the reported putative HBSs within both Flt-1 and ET-1 HREs, revealed a sequence distinct from the tentative HIF-1 consensus sequence known from many other hypoxia-regulated HIF-1 target genes. In the present study we thus addressed the question of whether this unique HBS represents a consensus recognition sequence specific for HIF-2.
Materials and Methods

Cell culture
The human HeLa cervical carcinoma and Hep3B and HepG2 hepatoma cell lines were obtained from American Type Culture Collection (ATCC numbers CCL-2, HB-8064 and HB-8065, respectively). The mouse L929 fibroblast (ATCC CCL-1), the Hepa1 (also termed Hepa1c1c7) hepatoma and the human endothelial EAhy926 cell lines were kindly provided by V. O'Donnall (Bern, Switzerland), L. Poellinger (Stockholm, Sweden) and H. Joch (Zürich, Switzerland), respectively. Cell culture and hypoxic exposure was performed as described previously [4] . Bovine and porcine aortae were obtained from a local abattoir (Zürich, Switzerland). Primary bovine aortic endothelial cells (BAECs) and porcine aortic endothelial cells (PAECs) were detached by adding 0.125% (w/v) collagenase (Sigma) for 15 min and harvested by gentle scraping. Collected endothelial cells (ECs) were transferred to gelatine-coated Petri dishes and cultured as above.
RNA blot analysis
Total cellular RNA was prepared and RNA blots analysed as described previously [55] . Hybridization probes were kindly provided by the following persons: mouse HIF-2α, L. Poellinger; mouse HIF-3α, C.A. Bradfield (Madison, Wis., USA); human ARNT, Y. Fujii-Kuriyama (Tohoku, Japan); human glucose transporter-1 (Glut-1), B. Thorens (Lausanne, Switzerland); mouse Flt-1, H.H. Marti (Bad Nauheim, Germany); human ET-1, W. Moritz (Zürich, Switzerland). The mouse HIF-1α, mouse VEGF and human ribosomal protein L28 probes were obtained as reported previously [55] . Hybridization probes were labelled with α 32 P-dATP to a specific activity of 1×10 9 dpm/µg using the random primed labelling technique. The inter-species similarity between probe and target mRNA was always higher than 80%. This degree of similarity did not result in observable differences in signal intensities under the chosen hybridization and wash stringencies.
Protein extraction and immunoblot analysis Nuclear extracts were prepared and immunoblots analysed as described previously [35, 74] . Membranes were stained with Ponceau S (Sigma) to confirm equal protein loading and transfer. HIF-1α and HIF-2α were detected using a mouse monoclonal IgG 1 antibody (mgc3) [4] and polyclonal rabbit antibodies kindly provided by I. Flamme (Wuppertal, Germany), respectively. Horseradish peroxidase-coupled secondary goat anti-mouse antibodies (Pierce) and luminol (Sigma) chemiluminescent substrate were used for detection.
Electrophoretic mobility shift assay (EMSA)
The DNA sequences of the oligonucleotides probes used for EMSA are shown in Table 1 C. The probes were end-labelled with γ 32 P-ATP to a specific activity of 5×10 6 cpm/pmol using T4 polynucleotide kinase (MBI Fermentas). EMSAs and competition experiments were performed as described previously [35] . In vitro transcription and translation of HIF-1α, HIF-2α and ARNT was performed using the TNT-coupled transcription-translation system (Promega) primed with the plasmids pBluescript/HIF-1α3.2-3T7 [70] , pmHLF [10] or pBSArntKS+ [24] , respectively, as described previously [20] . For supershift analysis, 1 µl anti-HIF-1α (mgc3) [4] or anti-HIF-2α (190b, kindly provided by P. Ratcliffe, Oxford, UK) [63, 75] antibody was added to the completed binding reaction.
Reporter gene assays
Luciferase reporter gene constructs were obtained by inserting the oligonucleotides ET-1wt, ET-1 T , Flt-1wt and Flt-1 T into the blunted BamHI site 3′ to the luciferase gene present in the pGL3Pro-moter plasmid (Promega). Copy number and orientation of the oligonucleotides were determined by DNA sequencing using RVprimer4 (Promega). The construction of pGLHIF1.3 has been reported previously [35] . Transient transfections and determination of luciferase activity were carried out as described previously [55] .
Results
Widespread expression of HIF-1α and HIF-2α in cultured cells in vitro To determine the relative expression of HIF-1α, HIF-2α and HIF-3α mRNAs in various cell lines, human HeLa, Hep3B and HepG2, mouse L929 and Hepa1 and BAECs and PAECs were cultured under normoxic or hypoxic conditions for 4 h and mRNA levels determined by RNA blot analysis (Fig. 1A) . HIF-1α mRNA expression was detected in all cell lines tested; the highest HIF-1α levels were observed in the ECs. HIF-2α was expressed stronghypoxic induction of HIF-2α mRNA. Expression of the HIF-1 target genes Glut-1 and VEGF increased strongly upon hypoxic stimulation of all cell lines, with the exception of BAECs. mRNA expression levels of ET-1 and Flt-1 were too low to be detected in this blot.
Protein levels of HIF-1α and HIF-2α were determined by immunoblot analysis of nuclear extracts from cells cultured under normoxic or hypoxic conditions ( Fig. 1B and C, respectively) . Hypoxia strongly induced HIF-1α in HeLa and EAhy926 cells and in both primary ECs. HIF-2α, previously reported to be expressed in primary ECs [23, 42] , was also detected in hypoxic HeLa cells and, to a lesser extent, in EAhy926 cells, indicating that the expression of HIF-2α is not restricted to endothelial cells under in vitro cell culture conditions. These results confirmed the widespread expression of HIF-1α and HIF-2α [75] and raised the question of whether, and if so, how, these two HIFs can distinguish between their specific target genes.
Unique sequence composition of the putative HBSs located in the two endothelial cell-specific genes ET-1 and Flt-1 Table 1 A summarizes the HBSs described from all genes identified to date as direct targets of HIF-1 function. The HIF-1 consensus DNA binding site contains CGTG as the conserved core sequence, usually preceded by an adenosine and followed by a cytosine residue.
Comparison with the reported ET-1 and Flt-1 HBSs (Table 1 B) revealed an adenosine residue 5′ to the core sequence, which occurred otherwise very rarely at this position (1 out of 44). It is an astonishing coincidence that this sequence alteration was found in precisely the only two hypoxia-inducible genes that are expressed preferentially in endothelium, but are completely unrelated otherwise. We therefore hypothesized that ET-1 and Flt-1 are hypoxically up-regulated by HIF-2 rather than HIF-1, not because of predominant HIF-2α expression in ECs (see above), but due to preferential binding of HIF-2 to this unusual HBS.
Competition experiments show that HIF-1 binds less efficiently to the unique ET-1 and Flt-1 HBSs than to a prototypical HBS To investigate the HIF-binding properties of the HBScontaining oligonucleotides derived from the reported ET-1 and Flt-1 HREs (Table 1 C), we analysed nuclear extracts from normoxic or hypoxic human HeLa cells by EMSA (Fig. 2) . First, we demonstrated hypoxic induction of HIF-1 DNA-binding activity in these extracts using oligonucleotide probes derived from the transferrin (Tf) HRE that contains two adjacent HBSs shown previously to bind HIF-1 [55] . Homologous competition for DNA-binding by adding increasing molar excesses of unlabelled Tf oligonucleotides demonstrated the specificity 242 ly in PAECs and the human cell lines, but was hardly detectable in BAECs and the mouse cell lines, despite the use of a mouse HIF-2α hybridization probe. HIF-3α mRNA was not detectable in any of the cell lines tested and its expression pattern awaits further clarification. As expected, ARNT mRNA was expressed ubiquitously. Following normalization with respect to the signal obtained by hybridization with the ribosomal protein L28 cDNA probe, constitutive expression of HIF-1α and HIF-2α mRNA was found in all of the cell lines tested, except the human hepatoma cell lines, which showed conditions. Total RNA was isolated, blotted and subsequently hybridized to the indicated cDNA probes. Hybridization to the ribosomal protein L28 served as control for equal loading and blotting efficiency. The data shown were originally derived from the same Northern blot. B Immunoblot analysis of HIF-1α in nuclear extracts derived from HeLa and EAhy926 cell lines as well as primary bovine (BAECs) and porcine (PAECs) aortic endothelial cells exposed for 4 h to normoxic or hypoxic conditions. C Immunoblot analysis of HIF-2α in nuclear extracts derived from HeLa and EAhy926 cells exposed for 4 h to normoxic or hypoxic conditions (ARNT aryl hydrocarbon receptor nuclear translocator, Glut-1 glucose transporter-1, VEGF vascular endothelial growth factor) In vitro-translated HIF-1 and HIF-2 both bind to the unique ET-1 HBS, but less efficiently than to the EPO HBS
We next aimed to establish whether HIF-1 or HIF-2 bound preferentially to the reported ET-1 and Flt-1 HBSs. Because nuclear extracts from most cultured cell lines usually contain both HIF-1 and HIF-2 (see above), we translated HIF-1α, HIF-2α and ARNT in vitro in separate reactions and subsequently allowed the corresponding subunits to heterodimerize. Following addition of the respective oligonucleotide probe, the reaction mixtures were analysed by EMSA (Fig. 3) . Using in vitro-translated HIFs, both HIF-1 and HIF-2 bound to an . DNA-binding activity was assessed by EMSA using the oligonucleotide probes described in Table 1 C and in vitro-synthesized HIF-1α, HIF-2α and ARNT proteins. Supershift analysis identifying the major DNA-binding protein complex was performed using mouse anti-HIF-1α (mgc3) and anti-HIF-2α (190b) monoclonal antibodies (EPO erythropoietin)
EPO control HBS with comparable efficiency. The presence of HIF-1α and HIF-2α was demonstrated by supershift experiments using specific antibodies that do not cross-react with any of the other two known α-subunits [4, 63, 75] . Equal protein addition to the EMSA reactions was verified by in vitro translation in the presence of 35 S-Met followed by SDS-PAGE analysis (data not shown). No DNA-binding activity could be observed when either of these three HIF subunits was analysed alone (data not shown).
The HIF-1 and HIF-2 DNA interaction with the ET-1wt probe was clearly reduced compared with that with the EPO probe, demonstrated by the fact that much longer exposure times were necessary to detect the ET-1wt bands. Interestingly, the relative DNA binding activity of in vitro-translated HIF-1 and HIF-2 was comparable between the EPO and the ET-1 probes, indicating that the unusual HBS sequence did not confer any preferential binding of HIF-1 or HIF-2, but rather attenuated overall DNA binding efficiency. To analyse the impact of the 5′-adenosine residue on HIF-1 and HIF-2 DNA binding, we "back-mutated" this residue to the more common thymidine (Table 1 C). As shown in Fig. 3 , this mutation of the ET-1 T probe restored both HIF-1 and HIF-2 DNA-binding efficiency fully, resulting in signal intensities similar to those obtained with the EPO probe. These results suggest that the unique HBS in the ET-1 HRE lowers HIF DNA binding activity rather than conferring specificity for either HIF.
Of note, neither Flt-1wt nor the back-mutated Flt-1 T oligonucleotides bound in vitro-translated HIF-1 or HIF-2, suggesting that the reported Flt-1 HRE apparently does not contain a functional HBS.
DNA interaction of HIF-1 with the ET-1 HRE is attenuated compared with that with the EPO HRE HeLa and endothelial EAhy926 cells were exposed to hypoxia and nuclear extracts analysed by EMSA (Fig. 4A and B, respectively) . Using an oligonucleotide probe derived from the EPO 3′-HRE, HIF DNA-binding activity was observed as well as a constitutive factor, shown previously to comprise activating transcription factor-1 (ATF-1) and cAMP-responsive element-binding protein-1 (CREB-1) family members [35] . Addition of the HIF-1α-specific monoclonal antibody mgc3 [4] resulted in a complete supershift of the HIF band, identifying HIF-1 as the major hypoxia-induced DNA-binding protein complex binding the EPO probe.
Similarly, completely supershifted HIF-1 DNA-binding activity was also observed using the ET-1wt probe, suggesting that HIF-1, rather than HIF-2 or HIF-3, represents the major factor binding to ET-1 HRE in these cell lines. The intensities of the ET-1wt bandshifts were reduced strongly compared with the EPO probe, indicating decreased DNA-protein interactions of HIF-1 and ATF-1/CREB-1 with the ET-1 probe. As with the in vitro-translated HIF proteins, adenosine-to-thymidine 245 back-mutation fully restored HIF-1 and ATF-1/CREB-1 DNA-binding activity to the level obtained with the EPO probe. Supershift experiments using an anti-HIF-2α antibody confirmed that the HRE in the ET-1 gene was bound by HIF-1 rather than HIF-2 (Fig. 4) .
Again, no supershiftable HIF-1 DNA-binding activity was observed using the Flt-1wt probe. Instead, only a non-specific band migrating in the gel between the induced and the supershifted HIF-1 DNA-binding activity was detected. The adenosine-to-thymidine back-mutation did not restore HIF-1 DNA-binding activity, but increased ATF-1/CREB-1 DNA-binding activity (Fig. 4) . Non-specific DNA binding activity was observed with all oligonucleotide probes used. The similar band intensities of this non-specific activity ruled out the possibility that differences in the HIF-1 and ATF-1/CREB-1 Fig. 4 Restoration of DNA-binding by adenosine-to-thymidine mutation of the ET-1 HBS. EMSAs were performed using the oligonucleotide probes described in Table 1 C and nuclear extracts derived from HeLa (A) or EAhy926 (B) cells. For supershift experiments anti-HIF-1α (mgc3) and anti-HIF-2α (190b) monoclonal antibodies were used series of luciferase reporter plasmids containing a heterologous simian virus-40 (SV40) promoter and three or four copies of the 18-bp oligonucleotides EPO, ET-1wt, ET-1 T , Flt-1wt or Flt-1 T (Table 1 C) inserted downstream from the luciferase gene (Fig. 5A ). HeLa and EAhy926 cells were transfected transiently and incubated under normoxic or hypoxic conditions or in the presence of the HIF-inducing iron chelator desferrioxamine (DFO). To correct the resulting luciferase expression levels for differences in transfection efficiencies, the cells were co-transfected with a β-galactosidase expression vector. Following normalization with respect to the β-galactosidase activity, the results were expressed as fold induction compared with normoxic controls (Fig. 5B) . Three copies of the EPO oligonucleotide conferred two-to fourfold induction of luciferase expression following hypoxic or DFO treatment of the cells. In contrast, hypoxia resulted only in a very moderate increase in luciferase expression in HeLa cells transfected with a plasmid containing three copies of the ET-1wt oligonucleotide. However, both cell lines showed a strong induction of luciferase activity after transfection with reporter plasmids containing three copies of the back-mutated ET-1 T oligonucleotide. This functionally confirms our findings that hypoxic regulation of ET-1 is attenuated by the critical 5′-adenosine residue and is fully restored after mutation to the more common thymidine residue.
As expected from the EMSA data (see above), both reporter constructs harbouring either the Flt-1wt or the Flt-1 T HBS oligonucleotides were unable to induce luciferase activity, suggesting that this HBS is apparently not sufficient to confer hypoxic induction to the reported Flt-1 HRE.
Discussion
HIF-1 and HIF-2 bind the same HBS and show a partially overlapping expression pattern in vivo. As in other recent reports [23, 75] , we showed that the two HIFs are also co-expressed in endothelial cells and diverse cell lines in vitro. However, while both HIF-1 and HIF-2 showed DNA-binding activity following in vitro translation, only HIF-1 DNA-binding activity could be detected in nuclear extracts. Intriguingly, while reports of HIF-2 DNA-binding assays with recombinant proteins have been published [10, 65] , no reports on HIF-2 DNA-binding activity in nuclear extracts are available to date. This might be due to a lower nuclear concentration of HIF-2 compared with HIF-1 or, alternatively, cell type-specific inhibitory factors of HIF-2 but not HIF-1 DNA-binding activity might be present in nuclear extracts but not in recombinant protein products. Specific interference by such factors with HIF-2 DNA-binding activity might provide one possibility for distinguishing functionally between these two closely related HIFs.
It remains, however, unclear whether, and if so, how, the two HIFs distinguish between particular target genes. Here, we demonstrated that the two endothelium-specific 246 DNA-binding activities were due to differences in oligonucleotide probe labelling or DNA-protein binding reaction efficiencies.
Decreased cis-activation of reporter gene expression by the unique ET-1 HBS compared with the EPO HBS To analyse the functional implications of the observed differences in DNA-binding activities, we constructed a HIF target genes ET-1 and Flt-1 contained an unusual adenosine residue 5′ to the core HBS consensus sequence. This finding provides a possible answer to the question, but the unusual ET-1/Flt-1 HBS did not mediate any significant binding preferences of HIF-1 or HIF-2. Rather, it attenuated both DNA-binding and transcriptional activation by the HIFs in the case of the ET-1 HBS, and even abolished these functions in the case of the Flt-1 HBS.
The Flt-1 HRE has been identified as a 40-bp fragment, located 959 bp upstream from the transcriptional start site, which is sufficient to mediate the anoxic induction of a heterologous reporter gene in Hep3B and HeLa non-ECs [19] . Of note, neither HRE function in hypoxic ECs nor HIF-1 binding to a putative HBS within this HRE have been demonstrated [19] . The use of a shorter oligonucleotide probe (18 bp) in our reporter gene and EMSA studies is unlikely to explain the lack of activity, because similar probes and constructs derived from the EPO and ET-1 genes functioned satisfactorily in our assays. Even chelation of iron (mimicking anoxic conditions) did not result in the functional activation of reporter genes containing three Flt-1 HBSs, suggesting that the degree of hypoxia is not related to the degree of HIF-dependent Flt-1 gene activation. However, severe hypoxia still might activate stress-inducible factors that confer activation of the longer Flt-1 HRE via HBS-independent cis-regulatory mechanisms.
Results concerning hypoxic up-regulation of VEGFRs are inconsistent. Systemic hypoxia up-regulates VEGFR1 but not VEGFR2 in mice [43] , but under other experimental conditions both VEGFR1 and VEGFR2 are induced under hypoxic conditions [67] . In addition, hypoxic VEGFR up-regulation is also mediated by paracrine factors including VEGF itself [1, 60, 68] . Thus, it is conceivable that hypoxic activation of the reported Flt-1 HRE requires factors in addition to HIF-1 or HIF-2 and/or that an additional HRE containing a functional, not yet identified, HBS might exist. Non-functional putative HBSs, despite a perfect match to the core consensus sequence, have been identified previously in the genes encoding glycolytic enzymes [58, 59] as well as HIF-1α itself [73] .
The HBS within the HRE of the ET-1 gene is critical for hypoxic induction. Whereas the GATA-binding transcription factor-2 (GATA-2) and activator protein-1 (AP-1) elements are essential for high-level expression of ET-1, only the HBS mutation abolished the hypoxic response [36, 37] . Indeed, ET-1 HBS is not sufficient for efficient hypoxic induction, but requires the additional DNA-binding elements for the AP-1 and GATA-2 transcription factors in the vicinity of the HBS [77] . Our data confirm this and suggest that HBSs containing the unusual 5′-flanking adenosine residue not only attenuate the hypoxic response but also allow this response to be triggered via other signalling pathways that culminate in the regulation of the HRE activity.
The extent of hypoxic ET-1 mRNA induction in vivo is rather low, e.g. threefold induction by hypoxia and 1.75-fold induction by CoCl 2 in human microvascular endothelial cells [46] . In rats exposed to 8% O 2 , anaemia (0.1% CO), haemorrhage or CoCl 2 , analysis of EPO and ET-1 mRNA expression showed comparable basal EPO and ET-1 mRNA expression levels in liver and kidney [54] . Interestingly, while hypoxia and anaemia increased EPO mRNA up to 150-fold in the kidney and 20-fold in the liver, ET-1 mRNA levels increased maximally fourfold under the same conditions. As shown in the present study, back-mutation of the wild-type ET-1 HBS to a EPO-like HBS restored DNA-binding and transcriptional activity to the same levels as those of the EPO HBS. This is evidence that the unusual ET-1 HBS serves to attenuate the hypoxic response of this very potent vasoconstrictor, thereby possibly limiting the extent of hypoxic vasoconstriction to physiologically meaningful levels.
